---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-23-000046"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2023-07-25T23:59:59+00:00"
generated_at: "2026-06-13T03:45:00.803590+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Merit Medical Q2 2023 revenue $320.1M (+8.5% YoY); non-GAAP EPS $0.81 beat

## Summary
- Q2 2023 revenue $320.1M, up 8.5% YoY; constant currency organic growth 9.1%.
- GAAP EPS $0.35 vs $0.27; non-GAAP EPS $0.81 vs $0.73, both YoY increases.
- GAAP operating margin 9.0% vs 7.9%; non-GAAP operating margin 19.9% vs 19.1%.
- No guidance update; results reflect broad-based growth across product lines.

## SEC filing metadata
- accession: 0000856982-23-000046
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2023-07-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698223000046/0000856982-23-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698223000046/mmsi-20230725x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-23-000046
- JSON: https://secwatch.observer/filing/0000856982-23-000046.json
- Plain text: https://secwatch.observer/filing/0000856982-23-000046.txt

## Key facts
- Earnings Releases
  MERIT MEDICAL SYSTEMS INC reported Q2 2023 results: revenue $320.1 million, EPS $0.35.
  - Period: Q2 2023
  - Revenue: $320.1 million
  - EPS: $0.35
  - Result: reported results
  source text: MERIT MEDICAL REPORTS RESULTS FOR SECOND QUARTER JUNE 30, 2023 ​ ● Q2 2023 reported revenue of $320.1 million, up 8.5% year-over-year ● Q2 2023 constant currency revenue* up 9.4% year over year ● Q2 2023 constant currency revenue, organic* up 9.1% year-over-year ● Q2 2023 GAAP operating margin of 9.0%, compared to 7.9% in Q2 2022 ● Q2 2023 non-GAAP operating margin* of 19.9%, compared to 19.1% in Q2 2022 ● Q2 2023 GAAP EPS $0.35, compared to $0.27 in Q2 2022 ● Q2 2023 non-GAAP EPS* of $0.81, compared to $0.73 in Q2 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/856982/000085698223000046/0000856982-23-000046-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.